Team:HokkaidoU Japan/Project/GSK
From 2011.igem.org
(Difference between revisions)
m |
m |
||
Line 1: | Line 1: | ||
{{Template:HokkaidoU_Japan}} | {{Template:HokkaidoU_Japan}} | ||
+ | <html><style> | ||
+ | .protein { | ||
+ | border-collapse: collapse; | ||
+ | border:1px solid #aaa; | ||
+ | margin:10px 0px 10px 20px; | ||
+ | text-align:left; | ||
+ | } | ||
+ | |||
+ | .protein th { | ||
+ | background-color:#eee; | ||
+ | font-weight:bold; | ||
+ | border-right:1px solid #aaa; | ||
+ | width:200px; | ||
+ | } | ||
+ | |||
+ | .protein td { | ||
+ | border-right:1px solid #aaa; | ||
+ | padding:2px 8px; | ||
+ | width:100px; | ||
+ | } | ||
+ | |||
+ | .protein tr:nth-child(even) { | ||
+ | border-bottom:1px solid #aaa; | ||
+ | } | ||
+ | </style></html> | ||
+ | |||
==GSK tag== | ==GSK tag== | ||
+ | |||
+ | {|class="protein" style="text-align:center;" | ||
+ | |- | ||
+ | !rowspan="2"|Name | ||
+ | |Registry | ||
+ | |2011 distribution | ||
+ | |length (bp) | ||
+ | |total molecular weight (kDa) | ||
+ | |- | ||
+ | |colspan="4" style="text-align:left;"|Discription | ||
+ | |} | ||
+ | |||
+ | {|class="protein" style="text-align:center;" | ||
+ | |- | ||
+ | !rowspan="2"|mnt repressor | ||
+ | |BBa_C0072 | ||
+ | |1-12L | ||
+ | |288 | ||
+ | |42.1 | ||
+ | |- | ||
+ | |colspan="4" style="text-align:left;"|Discription | ||
+ | |- | ||
+ | !rowspan="2"|Gal4 DNA binding domain | ||
+ | |BBa_K105007 | ||
+ | |3-9I | ||
+ | |438 | ||
+ | |47.6 | ||
+ | |- | ||
+ | |colspan="4" style="text-align:left;"|Discription | ||
+ | |- | ||
+ | !rowspan="2"|RFP | ||
+ | |BBa_J06504 | ||
+ | |1-13F | ||
+ | |714 | ||
+ | |57.7 | ||
+ | |- | ||
+ | |colspan="4" style="text-align:left;"|Discription | ||
+ | |- | ||
+ | !rowspan="2"|GFP | ||
+ | |BBa_E0040 | ||
+ | |1-14K | ||
+ | |720 | ||
+ | |57.9 | ||
+ | |- | ||
+ | |colspan="4" style="text-align:left;"|Discription | ||
+ | |- | ||
+ | !rowspan="2"|Cre DNA recombinase | ||
+ | |BBa_J61047 | ||
+ | |1-5D | ||
+ | |1037 | ||
+ | |69.6 | ||
+ | |- | ||
+ | |colspan="4" style="text-align:left;"|Discription | ||
+ | |- | ||
+ | !rowspan="2"|CCR5 | ||
+ | |BBa_I712002 | ||
+ | |2-3D | ||
+ | |1059 | ||
+ | |70.4 | ||
+ | |- | ||
+ | |colspan="4" style="text-align:left;"|Discription | ||
+ | |- | ||
+ | !rowspan="2"|LacI | ||
+ | |BBa_I732100 | ||
+ | |2-10E | ||
+ | |1086 | ||
+ | |71.4 | ||
+ | |- | ||
+ | |colspan="4" style="text-align:left;"|Discription | ||
+ | |- | ||
+ | !rowspan="2"|Luciferase | ||
+ | |BBa_I712019 | ||
+ | |1-10H | ||
+ | |1653 | ||
+ | |92.1 | ||
+ | |- | ||
+ | |colspan="4" style="text-align:left;"|Discription | ||
+ | |} | ||
{{:Team:HokkaidoU_Japan/footer}} | {{:Team:HokkaidoU_Japan/footer}} |
Revision as of 09:02, 2 October 2011
GSK tag
Name | Registry | 2011 distribution | length (bp) | total molecular weight (kDa) |
---|---|---|---|---|
Discription |
mnt repressor | BBa_C0072 | 1-12L | 288 | 42.1 |
---|---|---|---|---|
Discription | ||||
Gal4 DNA binding domain | BBa_K105007 | 3-9I | 438 | 47.6 |
Discription | ||||
RFP | BBa_J06504 | 1-13F | 714 | 57.7 |
Discription | ||||
GFP | BBa_E0040 | 1-14K | 720 | 57.9 |
Discription | ||||
Cre DNA recombinase | BBa_J61047 | 1-5D | 1037 | 69.6 |
Discription | ||||
CCR5 | BBa_I712002 | 2-3D | 1059 | 70.4 |
Discription | ||||
LacI | BBa_I732100 | 2-10E | 1086 | 71.4 |
Discription | ||||
Luciferase | BBa_I712019 | 1-10H | 1653 | 92.1 |
Discription |